ZAMBRUNI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 1.273
EU - Europa 921
AS - Asia 290
AF - Africa 60
OC - Oceania 2
Totale 2.546
Nazione #
US - Stati Uniti d'America 1.273
GB - Regno Unito 283
SE - Svezia 146
CN - Cina 126
DE - Germania 103
IT - Italia 95
VN - Vietnam 83
UA - Ucraina 75
IN - India 51
IE - Irlanda 50
RU - Federazione Russa 45
FR - Francia 38
TG - Togo 32
CH - Svizzera 27
EE - Estonia 25
ZA - Sudafrica 21
BG - Bulgaria 11
JO - Giordania 10
JP - Giappone 7
GR - Grecia 6
IR - Iran 6
BE - Belgio 5
SC - Seychelles 5
AT - Austria 4
SG - Singapore 3
FI - Finlandia 2
NZ - Nuova Zelanda 2
BY - Bielorussia 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
HU - Ungheria 1
KZ - Kazakistan 1
LB - Libano 1
MY - Malesia 1
NL - Olanda 1
RO - Romania 1
UZ - Uzbekistan 1
Totale 2.546
Città #
Southend 256
Chandler 178
Fairfield 133
Ashburn 95
Woodbridge 81
Wilmington 69
Houston 63
Seattle 57
Jacksonville 56
Princeton 55
Ann Arbor 52
Dublin 50
Cambridge 44
Lomé 32
Nanjing 30
Bern 26
Padova 25
Westminster 25
Dearborn 21
Boardman 15
Saint Petersburg 14
Changsha 13
Redwood City 12
Shenyang 12
Berlin 11
Sofia 11
Amman 10
Medford 10
Mülheim 10
New York 10
Turin 10
Tianjin 9
Jinan 8
Bologna 7
Nanchang 7
Tokyo 7
Bremen 6
Hebei 6
Jiaxing 6
Kuban 6
Norwalk 6
Brussels 5
Hangzhou 5
Kunming 5
Mahé 5
Milan 5
Mountain View 5
San Diego 5
Des Moines 4
Florence 4
Taizhou 4
Verona 4
Bühl 3
Castelnuovo Don Bosco 3
Fuzhou 3
Haikou 3
London 3
Olalla 3
Singapore 3
Beijing 2
Falls Church 2
Guangzhou 2
Hefei 2
Helsinki 2
Los Angeles 2
Ningbo 2
Paris 2
Pune 2
Salzburg 2
Washington 2
Zanjan 2
Zhengzhou 2
Abidjan 1
Almaty 1
Ardabil 1
Athens 1
Auckland 1
Boydton 1
Budapest 1
Buffalo 1
Cairo 1
Cedar Knolls 1
Cherry Hill 1
Chicago 1
Costa Mesa 1
Duino 1
Frankfurt Am Main 1
Kuala Lumpur 1
Lanzhou 1
Leawood 1
Mumbai 1
Palermo 1
Quzhou 1
Redmond 1
Rescaldina 1
San Francisco 1
San Mateo 1
San Venanzo 1
Taiyuan 1
Tallinn 1
Totale 1.680
Nome #
Combined mechanical and pharmacologic thrombolysis for portal vein thrombosis in liver-graft recipients and in candidates for liver transplantation. 154
Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20 year multicentre experience. 141
A novel sodium overload test predicting ascites decompensation in rats with CCL4-induced cirrhosis. 138
Cardiac electrophysiological abnormalities in patients with cirrhosis. 131
Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis. 126
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 123
Daily profile of circulating c-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects. Relationship with renal function. 117
Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. 113
C-type natriuretic peptide (CNP) favours natriuresis in pre-ascitic cirrhotic patients. 108
Torsade de pointes” during amiodarone infusion in cirrhotic woman with the prolonged QT interval. 107
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. 106
Terlipressin infusion induces ischemia of breast skin in a cirrothic patient with hepatorenal syndrome 106
QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis. 101
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. 101
QT Interval Correction in Patients with Cirrhosis 101
Effects of the combined treatment with thalidomide and megestrol in cirrhotic patients with advanced hepatocellular carcinoma. A pilot study. 100
Long-term beta-blockade shortens QT interval prolongation in patients with liver cirrhosis 96
Human herpesvirus-8-related Kaposi’s sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin. 90
La cardiomiopatia cirrotica. 85
Muscle atrophy in advanced cirrhosis: a neglected factor in the evaluation of regional hemodynamics 81
QT interval in patients with cirrhosis: failure of Bazett’s correction and identification of a disease-specific formula. 73
Muscle atrophy in advanced cirrhosis: a negleted factor in the evaluation of regional hemodinamycs 70
The etiology of viral cirrhosis affects the survival od patients with hepatocellular carcinoma. A case-control study. 68
La miocardiopatia del paziente cirrotico. Aspetti fisiopatologici e clinici. 66
Muscle atrophy in advanced cirrhosis: a negleted factor in the evaluation of regional hemodinamycs. 63
Evidence of oxidative imbalance in long-term liver transplant patients 14
QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt 3
Totale 2.582
Categoria #
all - tutte 6.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.202


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020681 112 15 9 30 69 78 92 81 95 42 24 34
2020/2021382 85 21 13 13 13 22 4 24 37 19 16 115
2021/2022506 23 16 34 41 40 20 8 27 17 19 162 99
2022/2023612 60 105 40 74 27 45 11 33 126 9 34 48
2023/2024126 5 26 7 17 10 37 1 3 12 5 1 2
Totale 2.582